source
- FDA approves Vera Therapeutics' Trutakna for IgA nephropathy, pricing set at $425,000 per yearThe U.S. Food and Drug Administration has granted approval to Trutakna, a new therapy from Vera Therapeutics, for the treatment of IgA nephropathy. IgA nephropathy is a kidney disorder where immun…
- ACA insurers seek median 14% premium hike for 2027 as enrollment fallsInsurers filing with state regulators for 2027 ACA plans are asking for a median premium increase of 14%, according to an analysis of filings in 16 states and the District of Columbia. This would…